U.S. Tech Hardware Stock News

NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Analog Devices (ADI) Net Margin Expansion Tests Bullish Long‑Term Profitability Narratives

Analog Devices (ADI) opened its new fiscal year with Q1 2026 results that sit on top of a clear ramp in recent quarters, with revenue moving from US$2,443.2 million in Q4 2024 to US$3,076.1 million in Q4 2025 and basic EPS stepping up from US$0.96 to US$1.60 over the same period. Over the trailing twelve months to Q4 2025, total revenue reached US$11.0 billion and basic EPS came in at US$4.59. This gives investors a fuller sense of earnings power coming into this latest print and sets the...
NasdaqGS:ROIV
NasdaqGS:ROIVBiotechs

A Look At Roivant Sciences (ROIV) Valuation After PHocus Trial Milestone And Weak Quarterly Earnings

Clinical and earnings updates shift focus for Roivant Sciences (ROIV) Roivant Sciences (ROIV) shares are in focus after the company reported a key clinical milestone for its pulmonary hypertension program and quarterly results that showed lower sales and a larger net loss compared with last year. See our latest analysis for Roivant Sciences. The clinical milestone and latest earnings are landing against a backdrop of strong momentum, with Roivant Sciences showing a 30 day share price return...
NYSE:BLCO
NYSE:BLCOMedical Equipment

Bausch + Lomb (BLCO) Loss Narrows To US$28m As Margin Repair Narrative Gains Traction

Bausch + Lomb (NYSE:BLCO) has put out its latest FY 2025 numbers with Q3 revenue of US$1.3b and a basic EPS loss of US$0.08, as investors weigh how far the business has come toward closing the profitability gap. The company has seen quarterly revenue move from US$1.1b in Q1 2025 to US$1.3b in Q3, while basic EPS losses over that stretch ranged from US$0.60 in Q1 to US$0.18 in Q2 and US$0.08 in Q3. This sets up the current update as a check-in on how quickly margins can repair from here. See...
NYSE:RBA
NYSE:RBACommercial Services

RB Global (RBA) Margin Slippage Tests Bullish Multi Year Earnings Growth Narrative

RB Global (RBA) has wrapped up FY 2025 with fourth quarter revenue of US$1.2 billion and basic EPS of US$0.53, alongside net income excluding extra items of US$99.1 million. This sets a clear marker for how the year finished. Across recent periods, the company has seen quarterly revenue range from US$981.8 million in Q3 2024 to US$1.2 billion in Q4 2025, while basic EPS moved between US$0.36 and US$0.56 over that span. This gives investors a concrete view of how the top and bottom lines have...
NasdaqGS:KRYS
NasdaqGS:KRYSBiotechs

Is Krystal Biotech (KRYS) Priced Right After A 61% One-Year Share Gain?

If you are wondering whether Krystal Biotech's share price reflects its true worth, this article will walk through how the current market price compares with a range of valuation checks. The stock last closed at US$283.29, with returns of 3.9% over 7 days, 14.7% year to date, and 60.8% over the past year. This performance has put it firmly on many investors' radar. Recent interest in Krystal Biotech has been shaped by ongoing attention to its gene therapy pipeline and regulatory milestones...
NYSE:SMWB
NYSE:SMWBSoftware

Similarweb (SMWB) Q4 Loss Widens As Profitability Timeline Faces Bullish Narrative Test

Similarweb (SMWB) has wrapped up FY 2025 with Q4 revenue of US$72.8 million and a basic EPS loss of US$0.09, alongside net income excluding extra items of a US$7.5 million loss. The company has seen revenue move from US$65.6 million in Q4 2024 to US$72.8 million in Q4 2025, while quarterly basic EPS shifted from a US$0.07 loss to a US$0.09 loss over the same period. This sets up a story focused on how quickly margins can tighten or ease from here. See our full analysis for Similarweb. With...
NYSE:MCO
NYSE:MCOCapital Markets

Moody's (MCO) Margin Strength Reinforces Bullish Narratives Despite Premium Valuation Concerns

Moody's (MCO) has just posted third quarter FY 2025 revenue of US$2.0b and basic EPS of US$3.61, with trailing twelve month revenue at US$7.5b and EPS at US$12.48 framing the latest print within a larger earnings run rate. The company has seen quarterly revenue move from US$1.82b in Q2 2024 to US$1.90b in Q2 2025 and then US$2.01b in Q3 2025, while basic EPS moved from US$3.03 to US$3.22 and then US$3.61 over the same quarters, giving investors a clear view of how the income statement is...
NasdaqGS:GSHD
NasdaqGS:GSHDInsurance

Goosehead Insurance (GSHD) Margin Compression Challenges Bullish Earnings Growth Narratives

Goosehead Insurance (GSHD) closed FY 2025 with fourth quarter revenue of US$105.3 million and basic EPS of US$0.50, alongside trailing twelve month revenue of US$365.3 million and EPS of US$1.11 that frame the latest print in a wider context of reported earnings. Over the past six quarters, revenue has moved from US$77.8 million in Q3 2024 to US$105.3 million in Q4 2025, while quarterly EPS has ranged from US$0.09 in Q1 2025 to US$0.60 in Q4 2024. This gives investors a clearer view of how...
NYSE:FVRR
NYSE:FVRRProfessional Services

Fiverr (FVRR) Earnings Growth And 5.2% Margin Test Bullish Profitability Narrative

Fiverr International (FVRR) just posted its FY 2025 numbers with Q3 revenue of US$107.9 million and basic EPS of US$0.15, set against trailing twelve month revenue of US$427.4 million and EPS of US$0.62 that reflect earnings growth of 121.2% over the past year. The company has seen quarterly revenue move from US$94.7 million in Q2 2024 to a range of roughly US$107 million to US$108.6 million across the first three quarters of 2025. Over the same 2025 periods, basic EPS shifted from US$0.09 in...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

IDEAYA Biosciences (IDYA) Q4 Loss Of US$83.3 Million Tests Bullish Growth Narrative

IDEAYA Biosciences (IDYA) has wrapped up FY 2025 with Q4 revenue of US$10.9 million, a basic EPS loss of US$0.94, and net income excluding extra items at a loss of US$83.3 million. Trailing twelve month figures show revenue of US$218.7 million and a basic EPS loss of US$1.28. Over recent quarters, the company’s revenue moved from US$7.0 million in Q4 2024 to US$207.8 million in Q3 2025 before landing at US$10.9 million in Q4 2025. Basic EPS ranged from a loss of US$1.49 in Q4 2024 to a profit...
NasdaqGS:ITRI
NasdaqGS:ITRIElectronic

Itron (ITRI) Margin Expansion To 12.7% Tests Slowing Growth Concerns

Itron (ITRI) closed out FY 2025 with Q4 revenue of US$571.7 million and basic EPS of US$2.25, set against trailing twelve month revenue of about US$2.4 billion and EPS of US$6.62 that followed 25.9% earnings growth over the last year. Over recent periods the company has seen quarterly revenue move between US$571.7 million and US$607.2 million with EPS ranging from US$1.43 to US$2.25, while the trailing twelve month net profit margin held at 12.7% versus 9.8% the prior year. This gives this...
NYSE:MED
NYSE:MEDPersonal Products

Medifast (MED) Q4 Loss Deepens Bearish Narratives On Earnings Sustainability

Medifast (MED) closed out FY 2025 with Q4 revenue of US$75.1 million and a basic EPS loss of US$1.65, alongside a trailing twelve month EPS loss of US$1.70 on revenue of US$385.8 million. Over the last six reported quarters, revenue has moved from US$140.2 million in Q3 2024 to US$75.1 million in Q4 2025, while quarterly EPS has ranged from a profit of US$0.23 in Q2 2025 to a loss of US$1.65 in Q4 2025. With the stock at US$10.71, the latest print keeps the focus firmly on pressure at the...
NYSE:RSI
NYSE:RSIHospitality

Rush Street Interactive (RSI) Profitability Shift Tests Bullish Earnings Narratives

Rush Street Interactive (RSI) closed FY 2025 with Q4 revenue of US$324.9 million and basic EPS of US$0.05, alongside net income of US$5.2 million, rounding out a year in which trailing twelve month revenue reached about US$1.1 billion and EPS came in at US$0.32. The company has seen quarterly revenue move from US$232.1 million in Q3 2024 to US$324.9 million in Q4 2025, while basic EPS shifted from US$0.01 to US$0.05 over the same stretch. This sets up a story that now hinges on how...
NasdaqGS:MCW
NasdaqGS:MCWConsumer Services

Mister Car Wash (MCW) Earnings Growth And 8.8% Margin Test Bullish Expansion Narratives

Mister Car Wash (MCW) has rounded out its FY 2025 reporting with Q3 revenue of US$263.4 million and basic EPS of US$0.08, set against trailing twelve month revenue of US$1.0 billion and EPS of US$0.28 that reflect an earnings growth rate of 25.5% over the past year. The company has seen quarterly revenue move from US$251.2 million in Q4 2024 to US$265.4 million in Q2 2025 before landing at US$263.4 million in Q3 2025. Basic EPS shifted from US$0.03 in Q4 2024 to around US$0.08 in each of the...
NasdaqGS:ITIC
NasdaqGS:ITICInsurance

Investors Title (ITIC) Margin Improvement Tests Long Term Earnings Decline Narrative

Investors Title (ITIC) just wrapped up FY 2025 with fourth quarter total revenue of US$69.5 million and basic EPS of US$3.98, alongside trailing 12 month EPS of US$19.10 on total revenue of US$273.9 million. The company has seen total revenue move from US$258.1 million and EPS of US$16.48 over the trailing 12 months to Q4 2024 to the latest trailing figures. Quarterly revenue has ranged between US$56.6 million and US$73.6 million and quarterly EPS between US$1.68 and US$6.51 across FY 2025,...
NYSE:ICL
NYSE:ICLChemicals

ICL Group (NYSE:ICL) Net Margin At 5.2% Tests Valuation Narratives Ahead Of Results

ICL Group (NYSE:ICL) has posted another steady quarter, with Q3 FY 2025 revenue of US$1.9 billion and basic EPS of US$0.09, supported by net income of US$115 million. Over the past few quarters, the company has seen revenue move from US$1.6 billion in Q4 FY 2024 to US$1.8 billion in Q2 FY 2025 and US$1.9 billion in Q3 FY 2025. Quarterly EPS has ranged between US$0.05 and US$0.09, setting up a results season in which investors are likely to focus closely on how resilient margins look from...
NasdaqGM:PRE
NasdaqGM:PREHealthcare

Prenetics Global (PRE) Quarterly Loss Narrows To US$5.5 Million Challenging Bearish Narratives

Prenetics Global (NasdaqGM:PRE) has just posted its FY 2025 third quarter numbers, with revenue of US$23.6 million and a basic EPS loss of US$0.40, keeping the company in loss-making territory. The company’s quarterly revenue has moved from US$10.5 million in Q4 2024 to US$17.3 million in Q1 2025, US$15.0 million in Q2 2025 and now US$23.6 million in Q3 2025. Over the same period, EPS losses have shifted from US$1.28 to US$0.80, US$0.64 and US$0.40. Investors are likely to weigh these results...
NYSE:HUN
NYSE:HUNChemicals

Huntsman (HUN) Loss-Making Quarter Extends Profitability Debate For Bulls And Bears

Huntsman (HUN) closed FY 2025 with fourth quarter revenue of US$1,355 million and a basic EPS loss of US$0.51, as the business continued to operate in the red on a trailing 12 month basis with EPS at a loss of US$1.59. Over the past six reported quarters, revenue has ranged between US$1,355 million and US$1,540 million, while basic EPS has stayed negative in every period. This highlights how top line stability has not yet translated into earnings stability. With analysts focused on a...
NasdaqGS:EQPT
NasdaqGS:EQPTTrade Distributors

Wall Street Backs EquipmentShare IPO Story With Growth And Valuation Upside

Wall Street brokerages have started coverage of EquipmentShare.com after its recent IPO, focusing on the company’s technology driven rental model. Analysts are highlighting EquipmentShare’s plans to expand its rental footprint and its capital light approach to fleet growth. The new coverage is drawing attention to the company’s goal of doubling rental locations and its position in the equipment rental industry. EquipmentShare.com, listed on NasdaqGS:EQPT, is coming onto more investors’...
NYSE:IQV
NYSE:IQVLife Sciences

IQVIA (IQV) EPS Surge To US$3.02 Tests Bearish Margin Concerns

IQVIA Holdings (IQV) just closed out FY 2025 with Q4 revenue of US$4.4b and basic EPS of US$3.02, capping a year in which trailing 12 month revenue came in at US$16.3b and EPS reached US$7.91. Over the past few quarters, the company has seen revenue move from US$3.8b in Q1 2025 to US$4.1b in Q3 2025 and US$4.4b in Q4 2025. Quarterly EPS went from US$1.42 to US$1.94 to US$3.02, setting the stage for investors to weigh that earnings trajectory against an 8.3% net margin that sits below last...
NasdaqGS:ACLS
NasdaqGS:ACLSSemiconductor

Axcelis Technologies (ACLS) Margin Compression Tests Bullish Silicon Carbide Growth Narrative

Axcelis Technologies (ACLS) just wrapped up FY 2025 with Q4 revenue of US$238.3 million and basic EPS of US$1.11, alongside trailing twelve month revenue of US$839.0 million and EPS of US$3.81 that frame the latest quarter in a fuller earnings picture. Over recent periods, the company has seen quarterly revenue range from US$192.6 million to US$238.3 million and quarterly EPS move between US$0.83 and US$1.11. During the same time, trailing twelve month revenue moved from US$958.1 million to...
NYSE:UCB
NYSE:UCBBanks

United Community Banks (UCB) Net Interest Margin Gain Backs Bullish Profitability Narrative

United Community Banks (UCB) has wrapped up FY 2025 with fourth quarter revenue of US$264.7 million and basic EPS of US$0.71, supported by trailing twelve month revenue of US$1.0 billion and EPS of US$2.62. The bank has seen revenue move from US$901.2 million and EPS of US$2.04 over the prior trailing period to US$1.0 billion and EPS of US$2.62 most recently, alongside a net profit margin of 31.4% versus 27.1% a year earlier. This puts the focus firmly on how efficiently it is turning its top...
NYSE:WAT
NYSE:WATLife Sciences

Waters Targets Growth With MaxPeak Columns And Four-Division Realignment

Waters Corporation (NYSE:WAT) introduced new high-sensitivity liquid chromatography columns featuring MaxPeak Premier Technology. The company completed a realignment of its operations into four focused divisions aimed at adjacent high-growth markets. Waters, a long-established player in analytical instruments and laboratory solutions, is using this product launch and business realignment to sharpen its role in analytical sciences and diagnostics. The new columns with MaxPeak Premier...